Skip to main content
. 2021 Oct 19;12:732913. doi: 10.3389/fimmu.2021.732913

Figure 1.

Figure 1

Immunometabolic proxies underlying the association between obesity and the severe course of COVID-19. Studies have associated the propensity of severe COVID-19 manifestation in patients with obesity and relevant metabolic comorbidities. The emerging theme indicates the immuno-pathological exaggeration of predisposed immuno-metabolic disorder (indicated in the circles, especially the overlapped region on the left) in the obese COVID-19 patients. This predisposed immunometabolic disorder magnifies, locally and systemically, the virus pathogenicity and relevant immunopathies leading to more severe COVID-19 manifestations. COVID-19, coronavirus disease 2019; SARS-CoV-2, severe acute respiratory syndrome coronavirus 2. Created with BioRender.com.